FDA Oversight of the Tissue Bank Industry

DSpace/Manakin Repository

. . . . . .

Title:	FDA Oversight of the Tissue Bank Industry
Author:	Wang, Mary H.
Citation:	FDA Oversight of the Tissue Bank Industry (2002 Third Year Paper)
Full Text & Related Files:	tissue_donation_paper_final_with_abstract.pdf (213.0Kb; PDF) tissue_donation_paper_final_with_abstract.rtf (96.08Kb; RTF file) tissue_donation_paper_final_with_abstract.html (76.4Kb; HTML)
Abstract:	Until recently, FDA oversight of the human tissue industry has been spotty, even nonexistent. However, industry explosion has forced the FDA to not only publish general industry standards in 1993 (finalized in 1997), but to update those standards with more comprehensive rules that are currently being reviewed. Needless to say, lack of adequate funding has proven problematic for the cash-strapped agency in terms of enforcing any regulations the agency hopes to promulgate.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852205